Skip to main content
logo
Britannia Life Sciences Inc. (CSE:BLAB)
Canada flag Canada · Delayed Price · Currency is CAD
0.0700
0.00 (0.00%)
Aug 27, 2026, 5:43 PM EST

Britannia Life Sciences Financials Overview

Millions CAD. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
0.410.470.370.526.47.3
Revenue Growth
6.04%28.58%-28.55%-91.93%-12.28%412.42%
Gross Profit
0.090.1-0.160.144.645.26
Operating Income
-1.45-1.46-2.22-1.550.991.62
Net Income
16.5414.657.39-4.775.08-15.46
Earnings Per Share
0.100.090.05-0.030.03-0.14
EPS Growth
122.06%98.18%----

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
12.4117.147.851.322.61.63
Total Debt
0.210.231.867.298.415.19
Net Cash (Debt)
12.216.915.99-5.96-5.81-3.56
Net Cash Growth
182.78%182.23%----
Net Cash Per Share
0.080.100.04-0.04-0.04-0.03

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-0.39-1.16-2.622.092.012.8
Capital Expenditures
-----0.06-0.09
Free Cash Flow
-0.39-1.16-2.622.091.952.71
Free Cash Flow Growth
---7.10%-27.99%-

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
22.83%21.41%-44.37%26.65%72.43%72.08%
Operating Margin
-357.47%-306.82%-599.98%-299.60%15.52%22.13%
Pretax Margin
3806.56%2860.35%-1235.00%-1183.40%91.48%-181.84%
Profit Margin
4069.61%3085.51%2001.95%-922.51%79.39%-211.76%
FCF Margin
-95.94%-243.50%-709.38%404.71%30.50%37.16%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
0.761.001.65-3.03-
P/FCF Ratio
---5.437.8911.34
PS Ratio
27.9430.7532.9521.982.414.21